Table 6. Economic burden of hospitalizations with cSSTI.
| Category, US$,mean|median [range] | All Hospitalizations | With antibiotic modification Treatment or not | MRSA or not | ||||
|---|---|---|---|---|---|---|---|
| YES (N = 336) | NO (N = 217) | P value | YES (N = 14) | NO (N = 61) | P value | ||
| Total | 2727.57 |1642.57[2.82–44567.79] | 3736.44 |2053.98[40.31–44567.76] | 1601.20|1272.86[2.82–13879.21] | <0.001 | 5215.21|1943.63[2.82–33205.76] | 2612.64|2145.61[44.73–19752.49] | 0.785 |
| Western medicine | 1041.30|524.57 [0–21412.2] | 1508.98|678.05[3.15–21412.24] | 524.69|388.30[0–3291.67] | <0.001 | 2629.23|704.94[0–21412.2] | 1004.45|658.40[7.62–10403.6] | 0.515 |
| Herbs | 258.98|49.18[0–2399.62] | 303.27 |186.01[0–2399.62] | 197.08|102.29[0–1093.17] | <0.001 | 220.45|102.65[2.82–952.55] | 280.92|159.23[0–1306.36] | 0.359 |
| Examination | 473.18|332.10[0–8135.65] | 590.73|401.40[5.09–8135.65] | 344.84|281.06[0–2619.76] | <0.001 | 525.61|395.69[0–1435.19] | 465.34|387.29[7.09–2783.24] | 0.590 |
| Treatment procedure | 756.41|304.50[0–17100.55] | 1078.27|427.40[5.57–17100.55] | 404.30|188.48[0–7648.55] | <0.001 | 1627.92|392.55[0–11156.2] | 659.11|354.35[15.14–4283.48] | 0.669 |
| Bed | 189.27|124.20[0–2954.84] | 240.89|155.65[2.69–2954.84] | 124.27|99.68[0–1122.58] | <0.001 | 200.25|157.26[0–700] | 194.06|150.97[2.98–951.61] | 0.883 |
| Diagnosis | 8.43|6.29[0–49.84] | 10.29|7.98[0–49.84] | 6.04|5.32[0–28.06] | <0.001 | 11.74 |9.19[0–30] | 8.75|7.26[0.48–26.61] | 0.287 |
The cost of different groups: patients with versus without antibiotic drug modifications; patients with MRSA versus MSSA were compared. Wilcoxon rank sum test is used for P value calculation.